NextCure and Avere to merge, targeting oral IL-23 therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. AVGO
7. SPCX
8. DE
9. OSIS
10. REAX

Go back to NextCure and Avere to merge, targeting oral IL-23 therapy
(NASDAQ: AKRO) Delayed: 54.74 --0 (-0%)
Previous Close $54.74    52 Week High $ 
Open $54.74    52 Week Low $ 
Day High $54.74    P/E N/A 
Day Low $54.74    EPS $ 
Volume 8,001,698       

(NASDAQ: NXTC) Delayed: 6.29 +0.04 (0.64%)
Previous Close $6.25    52 Week High $ 
Open $6.19    52 Week Low $ 
Day High $6.58    P/E N/A 
Day Low $6.19    EPS $ 
Volume 36,974